Crinetics Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,110.5% | 4,588.9% | 250.4% | 394.2% | 485.2% | 1,067.9% | 794.8% | 1,256.6% | 979.6% | 1,976.8% | – | 2,341.2% | 3,782.9% | 19,523.9% | – | – | – | – | 365,708.7% | 346,555.3% | 2,282.4% | 902.3% | 7,515.9% | 6,984.1% | 5,217.3% | 1,435.9% | 4,113.4% | 12,670.2% | – | 74.1% | 188.7% | – | – | 0.0% | 93.0% | 63,261.5% | -7.5% | 1.9% | 0.6% | 214.3% | |
| -765.9% | -4,488.9% | -150.4% | -294.2% | -385.2% | -967.9% | -694.8% | -1,156.6% | -879.6% | -1,876.8% | – | -2,241.2% | -3,682.9% | -19,423.9% | – | – | – | – | -365,708.7% | -346,555.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 98.1% | 99.4% | 99.2% | |
| 865.9% | 4,588.9% | 250.4% | 394.2% | 485.2% | 1,067.9% | 794.8% | 1,256.6% | 979.6% | 1,976.8% | – | 2,341.2% | 3,782.9% | 19,523.9% | – | – | – | – | 369,278.8% | 348,161.2% | 2,282.4% | 902.3% | 7,515.9% | 6,984.1% | 5,217.3% | 1,435.9% | 4,113.4% | 12,670.2% | – | 8,334.5% | 14,622.6% | – | – | 21,119.1% | 7,788.7% | 63,261.5% | 1,380.5% | 932.4% | 397.5% | 890.6% | |
| 260.3% | 1,308.9% | 47.1% | 76.7% | 88.4% | 282.4% | 170.2% | 316.1% | 327.9% | 859.9% | – | 774.5% | 1,056.7% | 5,621.1% | – | – | – | – | 100,000.0% | 100,000.0% | 682.9% | 278.1% | 2,389.3% | 2,603.7% | 1,590.1% | 455.0% | 1,350.5% | 4,475.1% | – | 3,254.4% | 6,225.1% | – | – | 9,841.0% | 4,834.3% | 36,549.0% | 871.6% | 473.6% | 229.2% | 508.5% | |
| 1,126.1% | 5,797.8% | 197.5% | 370.9% | 473.7% | 1,250.2% | 865.0% | 1,472.6% | 1,207.6% | 2,736.8% | – | 3,015.6% | 4,739.6% | 25,045.1% | – | – | – | – | 100,000.0% | 100,000.0% | 2,965.3% | 1,180.4% | 9,905.2% | 9,587.8% | 6,807.5% | 1,890.9% | 5,463.9% | 17,145.4% | – | 11,588.9% | 20,847.6% | – | – | 30,960.1% | 12,623.0% | 99,810.5% | 2,269.6% | 1,405.9% | 626.7% | 1,401.7% | |
| -1,026.1% | -5,797.8% | -197.5% | -370.9% | -473.7% | -1,250.2% | -865.0% | -1,472.6% | -1,207.6% | -2,736.8% | – | -3,015.6% | -4,739.6% | -25,045.1% | – | – | – | – | -465,708.7% | -446,555.3% | -2,865.3% | -1,080.4% | -9,805.2% | -9,487.8% | -6,707.5% | -1,790.9% | -5,363.9% | -17,045.4% | – | -11,488.9% | -20,747.6% | – | – | -30,860.1% | -12,523.0% | -99,710.5% | -2,169.6% | -1,307.8% | -527.3% | -1,302.5% | |
| 1.9% | 4.4% | 0.4% | 0.3% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 783.1% | – | – | – | – | 410.6% | 385.4% | 9,984.0% | 6.2% | 164.0% | 327.5% | 268.5% | 74.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1,021.9% | -5,791.1% | -198.1% | -372.2% | -477.5% | -1,236.2% | -847.5% | -1,384.7% | -1,087.7% | -2,456.7% | – | -2,857.4% | -4,532.4% | -24,450.7% | – | – | – | – | -465,815.8% | -447,261.9% | -2,856.6% | -1,105.9% | -9,652.6% | -9,153.9% | -6,345.7% | -1,716.9% | -5,159.8% | -16,606.4% | – | -10,457.8% | -18,560.2% | – | – | -26,807.2% | -11,216.0% | -90,972.7% | -1,990.5% | -1,191.0% | -481.1% | -1,189.5% | |
| 0.0% | 0.0% | -0.7% | -1.6% | -4.5% | -0.5% | -5.5% | -9.5% | -26.6% | -275.2% | – | -165.3% | -71.3% | -783.1% | – | – | – | – | -410.6% | -385.4% | -9,984.0% | 25.6% | -152.6% | -333.8% | -361.8% | -74.0% | -213.3% | -78.9% | – | 0.0% | – | – | – | – | – | – | 2.9% | – | – | – | |
| -1,021.9% | -5,791.1% | -198.1% | -372.2% | -477.5% | -1,236.2% | -847.5% | -1,384.7% | -1,087.7% | -2,456.7% | – | -2,857.4% | -4,532.4% | -24,450.7% | – | – | – | – | -465,815.8% | -447,261.9% | -2,856.6% | -1,105.9% | -9,652.6% | -9,153.9% | -6,345.7% | -1,716.9% | -5,159.8% | -16,606.4% | – | -10,457.8% | -18,560.2% | – | – | -26,807.2% | -11,216.0% | -90,972.7% | -1,993.4% | -1,191.0% | -481.1% | -1,189.9% | |
| – | -5,726.7% | -194.7% | -367.5% | -468.2% | -1,239.4% | -853.4% | -1,447.3% | -1,061.1% | -2,682.3% | – | -2,970.5% | -4,668.2% | -24,714.1% | – | – | – | – | -461,710.1% | -443,520.2% | -2,834.8% | -1,098.3% | -9,603.6% | -9,099.8% | -6,306.2% | -1,706.3% | -5,131.5% | -16,527.5% | – | -10,383.8% | -18,371.4% | – | – | -26,551.0% | -11,123.0% | -90,265.0% | -1,974.4% | -1,180.2% | -523.1% | -1,206.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.